NissensonA.R., KorbetS., FaberM., BurkartJ., GentileD., HamburgerR.Multicenter trial of erythropoietin in patients on peritoneal dialysis.J Am Soc Nephrol1995; 5: 1517–29.
2.
BaranyP., ClyneN., HylanderB., JohanssonA–C, SimonsenO., LarssonR.Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.Perit Dial Int1995; 15: 54–60.
3.
MatO., StolearJ–C, GeorgesB.Blood lipid profile in hemodialysis patients treated with human erythropoietin.Nephron1992; 60: 236–7.
4.
VironB., DonsimoriR., MichelC., KhayatR-Al, MignonF.Effect of recombinant human erythropoietin on nutritional status and plasma lipids in uremic patients.Nephron1992; 60: 249.
5.
PollockC.A., WyndhamR., CollettP.V., ElderG., FieldM.J., KalowskiS.Effects of erythropoietin therapy on the lipid profile in end-stage renal failure.Kidney Int1994; 45: 897–902.
6.
AllegraV., MartimbiancoL., MengozziG., VasileA.Erythropoietin and cardiovascular risk.Blood Purif1995; 13: 301–13.
7.
ManitiusJ., SzolkiewiczM., MysliwskaJ., ZorenaK., MysliwskiA., JakubowskiZ.Influence of “non-hematological” doses of erythropoietin on lipid-carbo-hydrate metabolism and life quality in hemodialysis patients.Nephron1995; 69: 363–4.
8.
CengizK.Does recombinant human erythropoietin affect plasma lipids in hemodialysis patients?Nephron1996; 74: 731–2.
9.
MakR.H.K.Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia.J Pediatr1996; 129: 97–104.
10.
AllegraV., MartimbiancoL., VasileA.Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.Nephrol Dial Transplant1997; 12: 924–32.
KronenbergF., TrenkwalderE., KronenbergM.F., KonigP., UtermannG., DieplingerH.Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a).Kidney Int1998; 54: 1385–9.
14.
BorissovaA.M., DjambazovaA., TodorovK., DakovskaL., TankovaT., KirilovG.Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis.Nephrol Dial Transplant1993; 8: 93–5.
15.
MakR.H.K., De FronzoR.A.Glucose and insulin metabolism in uremia.Nephron1992; 61: 377–82.
16.
BurkartJ.M., FreedmanB.I., RoccoM.V.The effect of increasing hematocrit on peritoneal transport kinetics.J Am Soc Nephrol1994; 4: 1726–32.
17.
GarfagniniA., DevotoG., RosseliP., BoggianoP., VenturiniM.Relationship between HDL-cholesterol and apolipoprotein A1 and severity of coronary artery disease.Eur Heart J1995; 16: 465–70.
